Clinical trial

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03

NCT03420781

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Relamorelin Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2018-01-24

PhasePHASE3

Conditions

Gastroparesisverified · MONDO: gastroparesis

Diabetes Mellitusverified · MONDO: diabetes mellitus

Interventions

PlaceboDRUG

RelamorelinDRUG

Sponsors & collaborators

Allerganlead sponsor

Mapped research locations

MiamiFlorida, United States5 Las VegasNevada, United States5 San AntonioTexas, United States4 ColumbusOhio, United States4 KyivUkraine4 HoustonTexas, United States3 SingaporeSingapore3 ClearwaterFlorida, United States3 KharkivUkraine3 GuadalajaraJalisco, Mexico3 VinnytsiaUkraine3 AtlantaGeorgia, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03420781 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.